Article Text

Download PDFPDF
Vaccination against the pneumococcus


Although most pneumococcal infection responds well to antibiotic therapy, there are conditions which place patients at a higher risk of more serious infection. Pneumococcal bacteraemia is rare, but kills about 25% of cases.1 Strains of pneumococci resistant to most antibiotics have recently appeared in Africa but are very rare in Europe. Antibody to the polysaccharide capsule of the organism is protective. A polyvalent vaccine of polysaccharides is now available for prophylactic active immunisation (Pneumovax - Thomas Morson).

Statistics from

Request Permissions

If you wish to reuse any or all of this article please use the link below which will take you to the Copyright Clearance Center’s RightsLink service. You will be able to get a quick price and instant permission to reuse the content in many different ways.